Transitional cell carcinoma of the prostate. Response to treatment with adriamycin and cis-platinum.
D000230:Adenocarcinoma / Q000175:diagnosis; D000368:Aged; D001932:Brain Neoplasms / Q000556:secondary; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis / Q000188:drug therapy*; D002945:Cisplatin / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis
D004317:Doxorubicin; D002945:Cisplatin